Drug Profile
Trientine tetrahydrochloride - Orphalan
Alternative Names: Cuprior; Cuvrior; TETA-4HClLatest Information Update: 12 Mar 2024
Price :
$50
*
At a glance
- Originator Orphalan
- Developer JACE PHARMA; Orphalan
- Class Ethylenediamines; Small molecules
- Mechanism of Action Chelating agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Hepatolenticular degeneration